NR1H4 and obesity disorder: Emerging evidence denoted that inhibition of intestinal FXR-FGF15 signaling resulted in prevention against high fat diet (HFD)-induced obesity and liver steatosis (Jiang et al., 2015a; Degirolamo et al., 2015).